Traders Purchase Large Volume of Evelo Biosciences Put Options (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the target of some unusual options trading activity on Wednesday. Stock investors acquired 1,885 put options on the company. This represents an increase of 1,101% compared to the average volume of 157 put options.

Evelo Biosciences Price Performance

Shares of EVLO opened at $0.00 on Friday. The firm has a market capitalization of $7,593.20, a PE ratio of 0.00 and a beta of 1.29. The firm has a 50-day moving average price of $0.01 and a 200 day moving average price of $0.03. Evelo Biosciences has a 52-week low of $0.00 and a 52-week high of $0.50.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.